Study discovers which liver tumours with β-catenin mutations respond to immunotherapy
An international study led by the University of Edinburgh, with the participation of the IDIBAPS Translational Research in Hepatic Oncology group,...
An international study led by the University of Edinburgh, with the participation of the IDIBAPS Translational Research in Hepatic Oncology group,...
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...
On World Cancer Day, held every year on 4 February, Clínic Barcelona Comprehensive Cancer Centre (4CB) highlights its excellence in patient care an...
MiWEndo Solutions and Reveal Genomics, spin-offs created by Clínic-IDIBAPS, have been selected among the ten innovative initiatives that will recei...
Elías Campo, head of the Molecular Pathology of Lymphoid Neoplasias research group at IDIBAPS ubicated at Esther Koplowitz Centre, has received a “...
On 14 January, the launch meeting of the European project CINNAMON (Connecting an INternational Network of Academic Manufacturers of ONcoimmunother...
Hospital Clínic Barcelona and the FERO Foundation have signed an agreement whereby the foundation joins the Clínic Barcelona Comprehensive Cancer C...
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Ann...
Hospitals that are part of the C17 alliance have launched the C17 Integrated Cancer Network (XIC-C17), an initiative aimed at strengthening coordin...
An international controlled clinical study published in The New England Journal of Medicine demonstrates that liquid biopsy can help identify which...